SCHEMBL20072439

SCHEMBL20072439

COSc1cccc(C(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
ALOX12 P18054 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MDM4 O15151 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
TYR P14679 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
CA5A P35218 1/20 0.40
MDM2 Q00987 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094580 0.85 HDAC4 (0.43) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL683932 0.77 CYP3A4 (0.44) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL18720480 0.75 HDAC4 (0.42) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL20072477 0.74 HTT (0.40) ALDH1A1ALOX12HTTSMN1; SMN2MAPT
SCHEMBL23252501 0.72 ACHE (0.48) ALDH1A1HTTSMN1; SMN2TDP1TP53
SCHEMBL374780 0.72 HDAC4 (0.56) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL21183168 0.72 HDAC4 (0.40) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL21102636 0.72 CYP3A4 (0.40) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL21101748 0.72 KDM4E (0.40) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL22561859 0.72 MCL1 (0.50) HDAC4HDAC8KDM4EALDH1A1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 HDAC4 2344/4885HDAC8 3692/4885KDM4E 3565/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 HDAC4 2081/4885HDAC8 3381/4885KDM4E 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.